Kanagawa, Japan

Kennunettsu Asaba

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kennunettsu Asaba. Retrieved from https://idiyas.com/inventor/kennunettsu-asaba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kennunettsu Asaba: Innovator in Guanidine Derivatives

Introduction

Kennunettsu Asaba is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on guanidine derivatives. His innovative approach has led to advancements in therapeutic applications for autoimmune and allergic diseases.

Latest Patents

Asaba holds a patent for a guanidine derivative and its medical use. This compound features a guanidine skeleton that inhibits the protease activity of MALT1. It has shown potential therapeutic and prophylactic effects on autoimmune diseases such as psoriasis and allergic conditions like atopic dermatitis. The guanidine derivative is characterized by a specific formula or a pharmacologically acceptable salt thereof. He has 1 patent to his name.

Career Highlights

Kennunettsu Asaba is currently employed at Toray Industries, Inc., where he continues to engage in innovative research. His work has been instrumental in developing new therapeutic strategies that address pressing medical needs.

Collaborations

Asaba collaborates with talented colleagues, including Yuki Matsumura and Kazuyuki Tokumaru. Their combined expertise fosters a productive research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Kennunettsu Asaba's contributions to the field of medicinal chemistry, particularly through his work on guanidine derivatives, highlight his role as an influential inventor. His ongoing research promises to yield significant advancements in the treatment of autoimmune and allergic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…